Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy for patients, who might be as young as age 2.

(00:32)
 Could you please tell us a little bit about your background?

(01:17)
 Could you please do a brief overview of our EOIBD test?

(03:24)
 Which patients should have this testing and when should it be performed?

(05:31)
 How are results used in patient care?

(07:02)
 What alternative test options are available and how do these compare to our test?